tert-Butyl ((6-chloropyrazin-2-yl)methyl)carbamate, 97%, 100mg

H-Gln-OH, 95%, 1kg

(R)-(6,6'-Dimethoxy-[1,1'-biphenyl]-2,2'-diyl)bis(diphenylphosphine), 97%, 5g

Methyl [(4,6-Dihydroxypyrimidin-2-yl)thio]acetate, 97.0%, 5g

((trans,trans)-4'-Pentyl-[1,1'-bi(cyclohexan)]-4-yl)methanol, 97.0%, 100g

(3-(N-(P-TOLYL)SULFAMOYL)PHENYL)BORONIC ACID, 95%, 1g

1-(7-Methoxy-4-methylquinazolin-2-yl)guanidine, 98.0%, 25mg

2-(2H-1,3-benzodioxol-5-yl)-3-iodoimidazo[1,2-a]pyridine, 95.0%, 1g

4-Fluoro-2-isopropoxybenzoic acid, 97%, 1g

4-Isopropylthiazole-2-carboxylic acid, 95.0%, 500mg

Mal-PEG1-NHS ester, 1g

Sorafenib>98.0%(HPLC)(T)500mg

2-(4-Bromophenyl)-4,6-diphenyl-1,3,5-triazine, 95.0%, 5g